Before I retired, I had a team of Project Managers who

New Post Public Reply Private Reply Replies (0) Message Board
hylander Zolis_onkel #26803
356
Before I retired, I had a team of Project Managers who reported up to me. So, I understand how deliverables work and how timetables get moved based on events that happened.

Basically, this was my job for over the last 7 or so years before I decided to retire. We worked with many different companies in many different fields. But the principles of Project Management and dealing with projects are always the same and the understanding that timetables can always be adjusted due to events happening.

That being said, we also had in each project plan the steps that needed to occur, outline, how many hours it takes, budget, who is responsible for doing it, meetings to discuss, updates and overuns. This was in the project team itself, then that gets reported to the upper management, etc on a bi-weekly or weekly report as well or internal meeting with upper management.

Everyone knows what's going on from start to finish. All the processes. It's the way it is.

Communication is the key in everything. Do shareholders need to know every little detail? No. Do shareholders need to know an accurate timeline when they are told one thing several times? yes. It doesn't mean they need a specific date, what it means, is if there is a process that needs to be done, outline the full process, don't leave out details that would add possible weeks to a timeline for results when you say 7-10 days you will have the results.

I think probably the biggest complaint has always been communication. I don't think anyone questions the science. Generex / NGIO certainly has the science here, it's the delivery of the message when we hear one thing and then we are told something a 'bit' different than what was originally told. It happens again and again.

I really hope and this is not an attack because I am so burned out now on being frustrated, I just really hope the communication gets way better and we start getting accurate communication from the company and we are not on a communication rollercoaster anymore. I can wait, I have been waiting for over 2 years now. Many of you have waited so much longer than I have, but I really want Generex / NGIO to succeed, I can have a bit more patience, but I just want better communication to go along with it.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Huawei Introduces Innovative Wearables for Enhanced Connectivity

Updated Category News Views 293

Huawei Unveils Next-Generation Wearables and Tablets At a much-anticipated event, Huawei Consumer Business Group (CBG) revealed a thrilling array of new products. This launch showcased a strong emphasis on trendy wearables and sophisticated tablets, highlighting the brand's dedication to innovation and a user-friendly design. Chic Wearables for Style and Utility Among the...

Continue Reading
Investigating Barnes & Noble Education: Shareholder Rights Explained

Updated Category News Views 155

Understanding the Investigation of Barnes & Noble Education In a proactive move for investors, the law firm Bragar Eagel & Squire, P.C. is currently investigating Barnes & Noble Education, Inc. (BNED). This investigation aims to determine whether the company potentially breached federal securities laws or engaged in unlawful business practices that could lead to...

Continue Reading
Bailey Kennedy Achieves Landmark Legal Win for Talisman Group

Updated Category News Views 171

Bailey Kennedy Achieves Legal Victory for Talisman Group Judge Rules LNW Violated Talisman's Distribution Agreement by Marketing Competing Game In a significant legal development, Bailey Kennedy, LLP has successfully represented The Talisman Group, LLC, the innovative minds behind EZ Baccarat. The firm has recently triumphed in a legal dispute against LNW Gaming, Inc.,...

Continue Reading
Join the Class Action Lawsuit Against Ardelyx, Inc. Now

Updated Category News Views 49

Join the Class Action Lawsuit Against Ardelyx, Inc. Attention Ardelyx, Inc. investors! There's an important class action lawsuit underway, and this is your opportunity to get involved. Bronstein, Gewirtz & Grossman, LLC, a respected law firm known for its dedication to investor advocacy, has announced a class action case involving Ardelyx, Inc. (NASDAQ: ARDX) and certain...

Continue Reading
Aileron Therapeutics Unveils Q3 2024 Financial Performance

Updated Category News Views 97

Aileron Therapeutics Reports Impressive Q3 2024 Financial Results Aileron Therapeutics, Inc. (NASDAQ: ALRN), a biopharmaceutical company committed to developing innovative medicines for orphan pulmonary diseases, has recently showcased significant progress with their third-quarter financial results. This quarter has been marked by promising advancements in clinical trials...

Continue Reading